BackInsight Molecular Diagnostics Overview

Insight Molecular Diagnostics Common Stock

Track Insight Molecular Diagnostics's common stock ($400M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$395.65M
↑ 7.36% YoYΔ $27.13M vs prior year quarter

Peer trimmed avg / median

Loading

Insight Molecular Diagnostics Common Stock History

Loading

Insight Molecular Diagnostics vs. peers: Common Stock Comparison

Loading

Insight Molecular Diagnostics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Insight Molecular Diagnostics (IMDX) FAQ

Insight Molecular Diagnostics (IMDX) currently reports a common stock of $400M as of September 2026. That compares with $370M in the prior-year period — up 7.4% year over year. Use the charts on this page to explore Insight Molecular Diagnostics's common stock history and peer comparisons.

Insight Molecular Diagnostics's common stock increased from $370M to $400M — a 7.4% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Insight Molecular Diagnostics reported $400M in common stock as of September 2026. That compares with $370M in the prior-year period — up 7.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $400M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Insight Molecular Diagnostics, and consider following IMDX for alerts when major investors trade the stock.

Insight Molecular Diagnostics is classified in the Technology sector. On common stock, it currently shows $400M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing IMDX with unrelated industries.

Questions & Answers